Myeloid fusion transcripts
Status
Material |
|
||
---|---|---|---|
Hint |
Fusionen mit den folgenden 29 Genen: ABL1, ALK, BCL2, BRAF, CCND1, CREBBP, EGFR, ETV6, FGFR1, FGFR2, FUS, HMGA2, JAK2, KMT2A (MLL), MECOM, MET, MLLT10, MLLT3, MYBL1, MYH11, NTRK3, NUP214, PDGFRA, PDGFRB, RARA, RBM15, RUNX1, TCF3, TFE3 | This analysis can be ordered by phone, after consultation with the consultation team, from bone marrow (stability 2 days) or asserved RNA. | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. | Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent). |
||
Stability |
Stability
1 day / 2-8°C
2 years / -20°C
|
||
Duration | 3 days | ||
Frequency | 2 x per week | ||
Method | Next Generation Sequencing |
Price/Rate
Price |
Price
CHF 954.90
|
---|---|
Rate |
Rate
954.90 TP
|